Skip to main
ACHC

Acadia Healthcare (ACHC) Stock Forecast & Price Target

Acadia Healthcare (ACHC) Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 31%
Buy 23%
Hold 38%
Sell 8%
Strong Sell 0%

Bulls say

Acadia Healthcare Co Inc anticipates achieving a net PLGL liability of $145-165 million by the end of 2025, reflecting its strategic growth and investment in behavioral health facilities. The company is experiencing strong demand in the sector, evidenced by impressive organic growth through bed expansions, new development, and a solid capacity for mergers and acquisitions due to robust capitalization. Furthermore, guidance suggests an improvement in organic earnings growth, which may offset some challenges posed by increased claims activity and operational risks in a competitive market.

Bears say

Acadia Healthcare Co Inc has experienced a series of downward revisions to its financial guidance, particularly due to higher-than-expected PLGL expenses, which are anticipated to impact the company's performance into 2026. This has led to a significant reduction in the 2025 EBITDA guidance by $94 million, or 13.4%, reflecting persistent volume softness and elevating litigation-related costs that exceed historical norms. Additionally, projections indicate that the company's EBITDA for fiscal year 2026 will decline further, suggesting ongoing pressure on margins and overall financial stability.

Acadia Healthcare (ACHC) has been analyzed by 13 analysts, with a consensus rating of Buy. 31% of analysts recommend a Strong Buy, 23% recommend Buy, 38% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Acadia Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Acadia Healthcare (ACHC) Forecast

Analysts have given Acadia Healthcare (ACHC) a Buy based on their latest research and market trends.

According to 13 analysts, Acadia Healthcare (ACHC) has a Buy consensus rating as of Mar 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $21.54, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $21.54, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Acadia Healthcare (ACHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.